Drug Trial Radar · NCT07772921
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,100
Planned (sponsor's estimate)
Start
Aug 20, 2026
Primary completion
Jun 1, 2029
Study completion Aug 24, 2029
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Aug 19, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life of people who are affected. The study is seeking participants who: * Have a history of severe asthma for at least 12 months * Have had at least 2 asthma attacks (also known as exacerbations) within the last 12 months All participants will be given shots of study medicine or a placebo at the study clinic. The study will compare the experiences of people receiving tilrekimig to those people who receive the placebo. This will help determine if tilrekimig is safe and effective.
Conditions
- Asthma
Interventions
tilrekimigDrug
subcutaneous injection
PlaceboOther
subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized asthma exacerbation rate over 52 weeksTime frame: Baseline through Week 52
Locations
16 sites in 2 countries. Site status is shown where the registry gives one.
Kern Research, Inc.
Bakersfield, California · Recruiting
Innovations Biotech
Miami, Florida · Recruiting
Chesapeake Clinical Research, Inc.
White Marsh, Maryland · Recruiting
Aa Mrc Llc
Flint, Michigan · Not yet recruiting
Revive Research Institute, Inc.
Southfield, Michigan · Not yet recruiting
Hudson County Clinical Trials Research Center, LLC
Union City, New Jersey · Recruiting
Monroe Biomedical Research
Monroe, North Carolina · Recruiting
Vital Prospects Clinical Research Institute., PC
Tulsa, Oklahoma · Not yet recruiting
Smyrna Advanced Research, LLC
Smyrna, Tennessee · Not yet recruiting
Inquest Clinical Research
Baytown, Texas · Not yet recruiting
SMS Clinical Research LLC
Garland, Texas · Recruiting
SMS Clinical Research, LLC
Mesquite, Texas · Recruiting
Victoria Clinical Research Group
Victoria, Texas · Not yet recruiting
Hiroshima Allergy & Respiratory Clinic Hacchobori
Hiroshima, Japan · Not yet recruiting
Kyushu Central Hospital
Minamiku, Fukuoka, Japan · Not yet recruiting
Showa Medical University Hospital
Shinagawa, Tokyo, Japan · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.